ImmunoGen Message Board - Msg: 34513719

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Area51 who wrote (5661)	12/19/2023 10:20:27 PM
From: Gary Mohilner	Read Replies (1) of 5665

I really think it should have been worth substantially more and that we could either get a counter offer or have Institutions balk at the price. I'm purchasing some cheap, just out of the buyout price options in the hope I'm right. The latest results revealed that it shouldn't be that long before IMGN has a second approved drug. IMGN ought to be valued at half of what SGEN was purchased for, they're getting a fraction of that. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next